The contractile properties of the urinary bladder are changed by the conditions of normal development and partial bladder outlet obstruction. This change in the contractile phenotype is accompanied by changes in the regulatory cascades and filaments that regulate contractility. This review focuses on such changes during the course of normal development and in response to obstruction. Our goal is to discuss the experimental evidence that has accumulated from work in animal models and correlate these findings with the human voiding phenotype.
Introduction
The urinary bladder serves to store urine at low pressures, and then in the appropriate time and place and under the coordinating control of the central and peripheral nervous system empty its contents to near completion. To effectively expel 95% of its stored volume, this system must be able to (1) generate intravesical pressure, (2) 
relax the bladder neck (a complex arrangement of smooth muscle under control of the autonomic nervous system) and (3) relax the striated external sphincter (which is under control of the somatic nervous system). Upon emptying its contents, the bladder then begins to slowly fill, a process that calls for suppression of the neural input that triggers contraction and a relaxation of the smooth muscle fibres during slow stretch to allow for lowpressure storage. Once the bladder has filled to its capacity, the sensation of the need to void is triggered, and the voiding cycle is initiated again. When the lower urinary tract is functioning normally, the average adult will empty their bladder six to eight times per day and be capable of a 3-to 4-hr interval free of the need to void. This voiding cycle will be affected by the process of normal development, stress, aging and disease. Patients will present with lower urinary tract symptoms (LUTS) that fall across a spectrum of severity such as urgency, frequent urination, nocturia or a slowing of the urinary stream; in some instances, these may progress to incontinence. The combined cost of caring for patients with these conditions in the United
States alone has increased to over US$ 10 billion annually [1] . The most common diseases affecting the lower urinary tract are 
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trauma resulting in stress incontinence in women, and the obstruction that results from benign prostatic hyperplasia (BPH) in men. It is clear that a better understanding of the pathophysiology of the LUTS that arise secondary to partial bladder outlet obstruction (pBOO) or contribute to stress urinary incontinence would allow for implementation of better pharmacological approaches to management of these conditions. The urinary bladder is composed of several distinct anatomic components and contains multiple cell types. The innermost layer or ruthenium is an epithelial surface that rests on a basement membrane and serves as a barrier to prevent absorption of urine. Below this urothelial layer is found the lamina propria, a layer that is rich in capillaries as well as a heterogeneous cell population composed of fibroblasts, myofibroblasts and a smaller population of cells that stain positive for c-kit known as the interstitial cells of Cajal. Moving beyond this layer, one finds bundles of long and slender smooth muscle cells encased in sheaths of extracellular matrix. An outer serosal layer is also noted and is composed primarily of what are thought to be fibroblasts. This microanatomic complexity allows the bladder to meet its functional needs, but it also makes the bladder a difficult organ to study in response to pathological conditions such as pBOO. It is clear that pBOO can affect multiple components of the bladder wall such as the microcirculation, extracellular matrix, nerves and muscle (Fig. 1). Studying the effects of pBOO on smooth muscle contractile function alone is challenging because of the confounding effects that are exerted by simultaneous changes taking place in the extracellular matrix and innervation. It is important to define the scope and limitations of this review, which will focus on smooth muscle contractility in the bladder under normal and pathological conditions. Once force is generated by the intracellular contractile filaments, it must be transmitted to the cell membrane and in turn to the extracellular matrix. This force transfer across the membrane to the extracellular matrix elements is of particular importance in smooth muscle, which must exert its forces within a hollow viscus. In contrast, force generated by skeletal muscle is transferred to bone by tendons. The tension transfer mechanism coupling actin filaments to a protein complex consisting of talin, vinculin, sarcoglycan and fibronectin is essential to normal force generation; diseases such as muscular dystrophy or
hollow visceral myopathy which affect this complex will also exhibit smooth muscle pathophysiology [2, 3] . Because adenosine-5Ј-triphosphate (ATP) is required for the generation of force, mitochondria indirectly contribute to force generation. Deficiencies in mitochondrial function have been noted in experimental models of pBOO [4, 5] , and patients with mitochondrial storage deficiencies may present with urinary retention [6] [17] and in vascular smooth muscle [18] . In a subsequent paper, Ekman et al. studied developmental changes in murine bladder muscle and observed a lower peak force was developed in the neonatal group as compared to the mature group [19] . Their work differed in that the bladder mucosa was stripped away from the mature bladders, although left intact in the neonates; this may well explain the difference noted with the paper by Wu et al. [16] Figure 2 , and these parameters correlated nicely with the gain in bladder mass. (Fig. 3) . [56, 57] Figure 4 [60]. Phosphorylated MLCK is dephosphorylated by an MLCK phosphatase, whose activity has been assayed in severe bladder wall hypertrophy and found to be diminished [61] . This low MLCK phosphatase activity is significant when one considers the shift from a phasic contraction in control tissue to a more tonic contraction seen in pBOO (Fig. 3) 
Much has been written about the use of cell culture as a means to study smooth muscle systems, but this must be tempered by the realization that once in vitro, a phenotypic shift or de-differentiation occurs in these cells. As an example, one can identify clearcut changes in the quantity as well as the isoform expression of bladder smooth muscle myosin heavy chain gene expression [48]. This instability in myosin heavy chain isoform expression leads these investigators to develop a cell line with a stable expression profile of the myosin heavy chains [49], which may then be used to answer a focused question as we will demonstrate later on. In summary, the use of cultured cells offers the benefit of a more 'homogeneous' cell population in which to test a specific hypothesis. The application of this technique will be highly dependent upon the preservation of expression of the genes and proteins of interest once the cells are placed in culture, and as of now cannot fully replace the use of a live animal model.
In vivo measures of pBOO in a rabbit model
The consequences of pBOO have been well-characterized in the rabbit model of pBOO using voiding pattern analysis, and in vivo videourodynamics. Placing the animal in a metabolism cage with a digital scale, which read at 2-min. interval, offers a means to non-invasively assess the voiding phenotype following pBOO. pBOO consistently leads to increase in voiding frequency as shown in
Using this same rabbit model, Stein et al. correlated the noninvasive voiding pattern data with an in vivo videourodynamic assessment of bladder function after pBOO [50]. Any rise in bladder pressure was monitored by fluoroscopy to confirm whether the rabbit was voiding. Fluoroscopic monitoring also allowed for an accurate determination of the post-void residual urine. Voiding pressures increased following pBOO, as would be expected given the increase in urethral resistance in a manner analogous to that described by Sullivan and Yalla [38]. As bladder mass increased, the voiding pressures also increased, but at the expense of a very large increase in post-void residual urine which was very accurately determined by aspiration with fluoroscopic confirmation. Unlike the human study of Sullivan and Yalla, we were unable to occlude the outlet in the rabbit to determine detrusor reserve. It must be pointed out that in a subset of bladders with the greatest increase in bladder mass and an elevated baseline cystometry pressure immediately prior to voiding, the sum of the residual and voided urine exceeded the infused volume. This is an experimental manifestation of a clinically observed phenomenon in patients with posterior urethral valves [51, 52] and is felt to reflect a post-obstructive diuresis, which in turn suggests that pBOO in this experimental model can lead to similar upper urinary tract changes. In summary, these data suggest that despite obvious limitations of such an acute model, surgically induced pBOO can recapitulate over a shorter time frame the following essential findings observed in human beings with pBOO: (1) an increase in bladder mass, (2) an increase in voiding frequency, (3) a drop in voided volumes, (4) increased voiding pressures, (5) a significant rise in post void residual urine in a subset of these bladders, (6) upon reversal of the outlet obstruction, residual urinary frequency was seen in 30% of the rabbits [53] and (7) evidence that at the extremes of pBOO, the upper tracts begin to sense increased resting bladder pressures as manifested by the post-obstructive diuresis.
Relating muscle strip studies to whole organ function
Myosin light chain phosphorylation
For many years it has been accepted that a critical element in the initiation of smooth muscle contractile force is the phosphorylation of the 20 kD myosin light chain
Regulation of myosin light chain de-phosphorylation
Initial studies of MLCK regulation focused on its activation by the Ca 2ϩ -calmodulin complex; it is now apparent that a complex regulatory system of kinases and phosphatases controls the state of MLCK phosphorylation and activity, which we have summarized in a simplified form in
SM-B and SM-A isoforms
Alterations in the thin contractile filaments
In addition to these findings in myosin heavy chain isoform expression, alterations in the expression of the thin filaments caldesmon and calponin have been described following pBOO.
The role of caldesmon in smooth muscle function has been recently reviewed [75] [76] . A similar finding was noted in a rat model of pBOO [77] . In these studies it was noted that in normal bladder the h-caldesmon isoform predominates, but with pBOO there is a marked shift towards the lcaldesmon isoform, which was associated with a diminished velocity and efficiency of contraction. This leads Shukla et al. [78] [80] . Further clarification of caldesmon's role in the regulation of bladder contractility will come as the voiding phenotype of this knockout mouse is characterized [81] .
Other thin filament regulatory proteins are expressed in smooth muscle and serve to modulate the actin-myosin interaction and these include h1-calponin as well as ␣-tropomyosin. The expression of these proteins at the mRNA and protein level has been demonstrated to increase following pBOO and these changes were localized to the detrusor smooth muscle myocytes using double immunofluorescence microscopy [82] . Matthews et al. studied the h1-calponin knockout mouse and noted that in bladder smooth muscle, there was no evidence for any changes in excitation contraction coupling, but there was a significant rise in the velocity of contraction in these knockout mice compared to their wild-type littermates [83] . Because these studies were also carried out in a permeabilized fibre preparation, it was possible for these investigators to add back exogenous calponin, and this in turn lead to a decline in velocity back to that see in the wild-type mice. These authors also noted that the h1-calponin knockout mice had an associated 25-50% decline in ␣-actin expression. Studies have been also performed in double knockout mice for SM-B and h1-calponin, which show an increased velocity of bladder contraction and peak force when compared to the SM-B knockout alone [84] . However, the extrapolation of these findings to the situation arising from pBOO alone is made more complicating by the fact that there is also a decline in smooth muscle ␣-actin levels as well as a rise in h-caldesmon levels in these double knockout mice which must also contribute to the observed physiology. The complex interactions and tight regulation of this family of filaments will challenge investigators hoping to control one variable at a time in an attempt to tease out the 'pure effect' of a particular filament. 
Alterations in tension transfer complex
